Cargando…
Clinical Characteristics of Myasthenia Gravis Patients with COVID-19 in Guangxi, China: A Case–Control Study
PURPOSE: With the adjustment of prevention strategies in December 2022, coronavirus disease 2019 (COVID-19) became widely prevalent in China. This study is aimed to describe the clinical characteristics of myasthenia gravis (MG) patients with COVID-19 and identify risk factors of exacerbation in MG...
Autores principales: | Zhou, Shaodan, Wen, Yishuang, Liu, Chao, Zhong, Jian, Liang, Manli, Wu, Yu, Lv, Sirao, Gong, Zhuowei, Lao, Dayuan, Li, Taiyan, Lu, Ting, Tang, Jingqun, Mo, Xuean, Huang, Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387240/ https://www.ncbi.nlm.nih.gov/pubmed/37525635 http://dx.doi.org/10.2147/JIR.S419307 |
Ejemplares similares
-
Inhibiting PI3K/Akt-Signaling Pathway Improves Neurobehavior Changes in Anti-NMDAR Encephalitis Mice by Ameliorating Blood–Brain Barrier Disruption and Neuronal Damage
por: Gong, Zhuowei, et al.
Publicado: (2023) -
DCAF12 and HSPA1A May Serve as Potential Diagnostic Biomarkers for Myasthenia Gravis
por: Nong, Weidong, et al.
Publicado: (2022) -
Risk Factors and Prognosis in Anti-NMDA Receptor Encephalitis Patients with Disturbance of Consciousness
por: Gong, Zhuowei, et al.
Publicado: (2023) -
Rare concurrent ocular myasthenia gravis and Graves’ ophthalmopathy in a man with Poland syndrome: a case report
por: Tang, Jingqun, et al.
Publicado: (2020) -
Update on ocular myasthenia gravis in Taiwan
por: Lin, Chao-Wen, et al.
Publicado: (2018)